The HER2 positive type of tiny breast tumours that apparently look cured after surgical operations are more likely to recur as compared to the bigger ones, American researchers said in a report on Friday.
After five years, 23 percent of patients with small tumours one cm (half an inch) or smaller whose cancer was HER2 positive had tumours come back after surgery, Gonzalez-Angula of the MD Anderson Cancer Centre in Houston told the San Antonio Breast Cancer Conference.
A new study says that taking folic acid and other vitamin B supplements do not lower cancer risk; however, the good news is that they don’t increase cancer risk either.
The study has been published in the Nov.5 issue of the Journal of the American Medical Association.
Study author, Dr. Shumin Zhang, who is an associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, in Boston, says: “We have found that in women at cardiovascular disease risk folic acid, vitamin B6 and vitamin B12 didn’t have any beneficial or harmful effects on their invasive or breast cancer risk.”
According to the U.S. Centers for Disease Control and Prevention, the government has mandated to add folic acid to cereals and breads, as their adequate levels in women have proven to prevent serious birth defects.
Breast cancer patients, going through endocrine treatment may show hot flashes, night sweats and joint symptoms which indicate toward gradual success of the treatment and reduction in estrogen level, that is a key risk factor of breast cancer, British researchers report.
They make comparison of women who reported these symptoms and those who didn’t, at their first visit during a trial evaluating tamoxifen or anastrozole for adjuvant therapy of postmenopausal breast cancer.
According to Israeli researchers, women with positive outlook in life have lower risk of developing breast cancer.
The study has been published in the BioMed Central journal and it also finds that being bereaved or getting divorced increase the risk of the cancer as well.
UK experts say that it’s hard to compare emotional stresses in different women. …Click here to read more
Bone building drugs show some hopes as a wider anti-cancer drugs
CHICAGO—There is a possible new way to fight against breast cancer as doctors are quite excited to find that a drug which is used to avoid bone loss during breast cancer cure may significantly lower the risk of reoccurrence of breast cancer.
Zometa and other bone-building drugs known as bisphosphonates show some hope as a wider anti-cancer drugs in this first large study. The cancers that already spread to the bone are treated by Zometa, a drug developed by Novartis AG.
1,800 premenopausal women who were getting hormone treatments for their initial stage breast cancer included in this new study. It was found that Zometa reduced almost one-third chances that the cancer would return. …Click here to read more
A new research has been conducted in the laboratories of Holland that the mammogram would help the female in securing their lives. This would also increase the life cycle of the women.
If we look at the cultural life of the Holland people, we would immediately imagine that the women are hard worker and inclined into social spheres than the men. The average life span of the Dutch woman is about 75 years.
The women are fighting with various cancer diseases in Holland. These are the lung cancer, breast cancer, brain tumor, liver cancer and blood cancer etc. Meanwhile the use of mammograms has increased the intensity of the women. Their life activities are the same as before the diagnosis of the cancer diseases. So they are more happy, secured and chilly.
Current genealogical researches about the breast cancer have risen up many questions and informative block of knowledge to the public. Doctors and scientists are saying that there are many perils involved in the study of breast cancer. Therefore the predictions are clinched up beyond the imagination of cancer study. Many famous institutes and universities of the UK and USA found a hereditary element which helps the researchers as well as to the patients to really feel free deterioration.
In this precession, the genomic stuff of the man’s body provides us a new kind of information and decision making about the clinical research and the diagnoses. A feel of threaten concern comes into mind before the scientists. Whether the data would find and analyzed in a more comprehensive and optimistic way to lead a best cancer cure and vice versa. Complexities’ do come but the probable result of clinical research makes it an easy cancer diagnosis.
Cancer in general is a disease in which cells begin to grow rapidly and without of any control. Cancer cells can travel through the body by the way of blood or lymph nodes. When it comes to the specific case of Breast Cancer, every woman could be at risk for breast cancer. The risk of breast cancer varies with age, typically for women below the age of 25 this risk is about 1 in 20,000 whereas at the age of 45, it is 1 percent and at age 85, it is more than 1 in 10.
Researchers are yet to find out why and how normal cells suddenly can become cancerous. Thus, the fundamental cause or causes of such type of cancer is still unknown but scientists have found out that certain risk elements are associated to the development of breast cancer. These elements include family breast cancer history of occurring in mother or sister and early beginning of menstruation and also late menopause. In other cases women do not breast-feed or Women who have no children or have children late in life have more risk.
